The utilization of dual-potential mode of integrated array (IDA) electrodes and other two-electrode systems has revolutionized electrochemical detection by enabling the simultaneous and independent detection of two species, accompanied by the exhibition of unique characteristics. In contrast to conventional dual-potential electrodes, the rotating ring disk electrodes (RRDE), IDA electrodes demonstrate analogous yet vastly improved performance metrics, characterized by remarkable collection efficiency and sensitivity. Notably, due to the distinctive microscale structure of IDA electrode, the special “feedback” effect makes IDA a unique signal amplifier. In recent decades, the research surrounding IDA electrodes has garnered escalating interest due to their attractive attributes. This review centers its focus on the fabrication and applications of IDA electrodes. In the realm of fabrication, two critical breakthroughs are poised for realization: the achievement of reduced dimensions and the diversification of materials. Established fabrication methods for IDA electrodes encompass photolithography, inkjet printing, and direct laser writing, each affording distinct advantages in terms of size and precision in IDA construction. Predominantly employed materials for IDA electrodes include gold, platinum, and carbon, with the selection of fabrication methods guided by considerations such as material properties, desired dimensions, cost-efficiency, and specific application requisites. Within the domain of applications, IDA electrodes, capitalizing on their distinctive attributes, have found utility in diverse fields. This review summarizes the applications of IDA electrodes based on their fundamental working principles, encompassing redox cycling, resistance modulation, capacitance variations, and more. The potential for further development of this specialized tool to exhibit enhanced properties holds substantial promise.

Background: Advancement of next-generation sequencing (NGS) technologies provides opportunities for large-scale Pharmacogenetic (PGx) studies and pre-emptive PGx testing to cover a wide range of genotypes present in diverse populations. However, NGS-based PGx testing is limited by the lack of comprehensive computational tools to support genetic data analysis and clinical decisions. Methods: Bioinformatics utilities specialized for human genomics and the latest cloud-based technologies are used for developing a bioinformatics pipeline for analyzing the genomic sequence data and reporting PGx genotypes. A database was created and integrated in the pipeline for filtering the actionable PGx variants and clinical interpretations. Strict quality verification procedures were conducted on variant calls with whole genome sequencing (WGS) dataset of the 1000 Genomes Project (G1K). The accuracy of PGx allele identification was validated using the whole genome sequencing dataset of the Pharmacogenetics Reference Materials from the Centers for Disease Control and Prevention (CDC). Results: The newly created bioinformatics pipeline, Pgxtools, can analyze genomic sequence data, identify actionable variants in 13 PGx relevant genes, and generate reports annotated with specific interpretations and recommendations based on clinical practice guidelines. Verified with two independent methods, we have found that Pgxtools consistently identifies variants more accurately than the results in the G1K dataset on GRCh37 and GRCh38. Conclusions: Pgxtools provides an integrated workflow for large-scale genomic data analysis and PGx clinical decision support. Implemented with cloud-native technologies, it is highly portable in a wide variety of environments from a single laptop to high performance computing clusters and cloud platforms for different production scales and requirements.